The Potential Strategies for Overcoming Multidrug Resistance and Reducing Side Effects of Monomer Tubulin Inhibitors for Cancer Therapy.

Cui, Yingjie; Zhang, Jing; Zhang, Guifang

Cui, Yingjie; Zhang, Jing; Zhang, Guifang.

Afiliação

Cui Y; Department of Pharmacy, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong, 250012, PR China.
Zhang J; Department of Pharmacy, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong, 250012, PR China.
Zhang G; Department of Pharmacy, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong, 250012, PR China.

Curr Med Chem ; 2023 Jun 22.

Article em En | MEDLINE | ID: mdl-37349994

Palavras-chave

Tubulin inhibitors; and cancer therapy.; multidrug resistance; protein degraders; side effects; tubulin-based dual-target inhibitors

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Curr Med Chem Assunto da revista: QUIMICA Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google